Agilis announces Intrexon deal, CEO and financing

Newco Agilis Biotherapeutics LLC (Germantown, Md.) announced a deal with synthetic biology company Intrexon Corp. (NYSE:XON), named a new

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE